2026 Non-CME/CE Bonus Presentations
Friday, January 16, 2026 | 12:35 PM – 1:45 PM
Beyond the Data: A Patient Centered Look at a Treatment for Moderate to Severe Atopic Dermatitis
Speaker: Diego DaSilva, MD, FAAD
Room: Royal Dublin
Sponsored by Pfizer
Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway for JAK Inhibition
Speaker: Adam Friedman, MD, FAAD
Room: Royal Melbourne
Sponsored by Incyte
Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
Speaker: Peter Lio, MD
Room: St. Andrews
Sponsored by Eli Lilly and Company
Program Description: Join us for “Explore EBGLYSS® (lebrikizumab-lbkz)”, an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and how to get patients started on EBGLYSS.
Saturday, January 17, 2026 | 9:05 AM – 10:15 AM
To Mohs or Not to Mohs
Speaker: Vishal Patel, MD
Room: Royal Dublin
Sponsored by Sun Pharmaceuticals
Program Description: Join us for an engaging session exploring the management of locally advanced basal cell carcinoma (laBCC) and the role of the hedgehog pathway in therapeutic decision-making.
Title: TBD
Speaker: TBD
Room: Royal Melbourne
Sponsored by Sanofi and Regeneron Pharmaceuticals Inc.
Title: TBD
Speaker: TBD
Room: St. Andrews
Sponsored by Eli Lilly and Company
Saturday, January 17, 2026 | 12:35 PM – 1:45 PM
Stronger Together with TREMFYA. Bridging Derm and Rheum for Psoriatic Care
Speaker: Jennifer Soung, MD
Room: Royal Dublin
Sponsored by Johnson & Johnson
Title: TBD
Speaker: TBD
Room: Royal Melbourne
Sponsored by Kenvue
Now Approved: A new path forward with RHAPSIDO® (remibrutinib)
Speaker: Adam Friedman, MD, FAAD
Room: St. Andrews
Sponsored by Novartis Pharmaceuticals Corporation
Program Description: This program will provide an insightful view of RHAPSIDO®, including:
- Mechanism of action with RHAPSIDO
- Demonstratedefficacy and safety data
- Getting patients started on RHAPSIDO
Saturday, January 17, 2026 | 4:45 PM – 5:45 PM
JDD Podcast LIVE: Behind the Bottle Part II: From Tingling to Tearing – The Data-Driven Approach to Sensitive Skin Syndrome and Dermatoporosis
Host: Adam Friedman, MD
Guest: Peter A. Lio, MD
Room: General Session
Sponsored by Cetaphil
This is a Non-CME/CE Session – JDD Podcast LIVE
Sunday, January 18, 2026 | 9:05 AM – 10:15 AM
Sailing into Clear Horizons
Speaker: Brad Glick, DO, MPH, FAAD
Room: Royal Dublin
Sponsored by AbbVie
Program Description: Sailing into Clear Horizons
Exploring Superiority Data From 5 Head to Head Clinical Trials in Moderate or Moderate to Severe Plaque Psoriasis
ZORYVE® (roflumilast): Discover a New Option in Topical Treatment
Speaker: Peter Lio, MD
Room: Royal Melbourne
Sponsored by Arcutis Biotherapeutics, Inc.
Program Description: Speaker will discuss latest innovation in topical therapies.
Sunday, January 18, 2026 | 12:20 PM – 1:30 PM
Adjuvant Treatment for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) at High Risk of Recurrence After Surgery and Radiation
Speaker: Vishal Patel, MD, FACMS
Room: Royal Dublin
Sponsored by Regeneron Pharmaceuticals Inc.
Title: TBD
Speaker: TBD
Room: Royal Melbourne
Sponsored by TBD
Sunday, January 18, 2026 | 5:45 PM – 7:45 PM
This is a Non-CME/CE Bonus Presentation – Invitation Only
Empowering the HS TrutHS Journey: Patient Voices and Pathway Science
Speakers: Steven Daveluy, MD, FAAD; Iltefat Hamzavi, MD, FAAD
Room: Royal Melbourne
Sponsored by Incyte
Program Description: Every patient living with HS has a story, and they’re not done telling it. Step into the stories of HS, where clinical decisions shape better conversations. In this interactive, expert-led, educational workshop, we’ll uncover the real HS TrutHS and provide tools to make an impact.
Title: TBD
Speaker: TBD
Room: Royal Dublin
Sponsored by Kenvue
